News and Announcements
Prescient Therapeutics Quarter Summary and Key Activities
- Published January 25, 2016 2:54PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
25th January 2016, ASX Announcement
Prescient Therapeutics Limited (“Prescient” or “the Company”) provides the following Appendix 4C in relation to the quarter ended 31 December 2015.
In January 2016, the Company carried out investor roadshows in the US meeting key instructions and investment advisors and also presented at Biotech Showcase 2016 in San Francisco and NobleCon12 in Florida.
Cash at 31 December 2015
Cash at the end of the quarter, as detailed in the attached Appendix 4C, was approximately $1.93 million.
Subsequent to the end of the quarter the Company has now received its 2014/2015 Research and Development Incentive Grant and Overseas Finding Grant amounting to $463,358.
Key activities during the quarter
During the quarter, the Company announced a Share Purchase Plan (SPP) fully which was underwritten up to a target amount of $1.03 million to underpin next stage development of its lead oncology costs. The SPP closed oversubscribed with $1.2 million worth of subscriptions received. All applications under the SPP were scaled back on an equal basis and a total of 17,174,368 full paid original shares were issued at $0.054 (5.5 cents) per share, being a 20% discount to the 5 day volume weighted average price (VWAP) before 23 November 2015.
To read the full announcement, please click here.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
